The University of Texas Health Science Center at Houston (UTHealth) Medical School has been chosen as one of the first 25 sites in the country to investigate the safety and efficacy of Edwards Lifesciences Sapien 3 transcatheter aortic heart valve for patients with severe aortic valve stenosis. The procedure will be done at the Memorial Hermann Heart & Vascular Institute-Texas Medical Center (HVI). Dr. Richard W. Smalling is the principal investigator of the Houston site on the Phase III study.

Read more about UTHealth/Memorial Hermann Launches Latest TAVR Trial